Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Survei membuktikan, mayoritas dosen Indonesia alami kekerasan di kampus

● Survei SPK menunjukkan pekerja kampus menghadapi kekerasan, eksploitasi, dan ketidakamanan.● Kerja paksa, tekanan psikologis, dan minimnya layanan kesehatan mental memicu stres tinggi da...

Bagaimana mendampingi anak melewati peristiwa traumatis?

PERINGATAN: Artikel ini memuat konten yang berkaitan dengan bunuh diri, melukai diri sendiri, dan kekerasan terhadap orang lain.● Peristiwa traumatis yang dialami langsung maupun didengar lewat ...

Rencana pembangunan Papua dan bayang-bayang ekonomi yang menguras alam

● Arah baru pembangunan Tanah Papua masih belum jelas di tengah rendahnya pembangunan manusia dan dan kemiskinan ekstrem.● Rencana lumbung sawit Prabowo berlawanan dengan target kelestaria...